These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9521483

  • 1. P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2.
    Tuluc F, Bültmann R, Glänzel M, Frahm AW, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):111-20. PubMed ID: 9521483
    [Abstract] [Full Text] [Related]

  • 2. P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.
    Wittenburg H, Bültmann R, Pause B, Ganter C, Kurz G, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):491-7. PubMed ID: 8897453
    [Abstract] [Full Text] [Related]

  • 3. P2-purinoceptor antagonists: I. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphonates.
    Bültmann R, Pause B, Wittenburg H, Kurz G, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):481-90. PubMed ID: 8897452
    [Abstract] [Full Text] [Related]

  • 4. P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin.
    Bültmann R, Wittenburg H, Pause B, Kurz G, Nickel P, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):498-504. PubMed ID: 8897454
    [Abstract] [Full Text] [Related]

  • 5. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens.
    Bültmann R, Trendelenburg M, Tuluc F, Wittenburg H, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):339-44. PubMed ID: 10344533
    [Abstract] [Full Text] [Related]

  • 6. Constitutional isomers of Reactive Blue 2 - selective P2Y-receptor antagonists?
    Glänzel M, Bültmann R, Starke K, Frahm AW.
    Eur J Med Chem; 2003 Mar; 38(3):303-12. PubMed ID: 12667697
    [Abstract] [Full Text] [Related]

  • 7. Reactive red 2: a P2y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase.
    Bültmann R, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):477-82. PubMed ID: 8751075
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.
    Windscheif U, Pfaff O, Ziganshin AU, Hoyle CH, Bäumert HG, Mutschler E, Burnstock G, Lambrecht G.
    Br J Pharmacol; 1995 Aug; 115(8):1509-17. PubMed ID: 8564212
    [Abstract] [Full Text] [Related]

  • 9. Structure-activity relationships of novel P2-receptor antagonists structurally related to Reactive Blue 2.
    Glänzel M, Bültmann R, Starke K, Frahm AW.
    Eur J Med Chem; 2005 Dec; 40(12):1262-76. PubMed ID: 16153748
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.
    Bültmann R, Dudeck O, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):445-51. PubMed ID: 8935712
    [Abstract] [Full Text] [Related]

  • 11. On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues.
    Bültmann R, Tuluc F, Starke K.
    Eur J Pharmacol; 1998 Oct 16; 359(1):95-101. PubMed ID: 9831299
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
    Bailey SJ, Hourani SM.
    Br J Pharmacol; 1994 May 16; 112(1):219-25. PubMed ID: 8032645
    [Abstract] [Full Text] [Related]

  • 13. The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses.
    Lambrecht G, Ganso M, Bäumert HG, Spatz-Kümbel G, Hildebrandt C, Braun K, Mutschler E.
    J Auton Nerv Syst; 2000 Jul 03; 81(1-3):171-7. PubMed ID: 10869717
    [Abstract] [Full Text] [Related]

  • 14. On the suitability of adenosine 3'-phosphate 5'-phosphosulphate as a selective P2Y receptor antagonist in intact tissues.
    Bültmann R, Tuluc F, Starke K.
    Eur J Pharmacol; 1998 Jun 19; 351(2):209-15. PubMed ID: 9687005
    [Abstract] [Full Text] [Related]

  • 15. Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.
    Bültmann R, Trendelenburg M, Starke K.
    Br J Pharmacol; 1994 Oct 19; 113(2):349-54. PubMed ID: 7834182
    [Abstract] [Full Text] [Related]

  • 16. P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus.
    Koch H, von Kügelgen I, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun 19; 355(6):707-15. PubMed ID: 9205954
    [Abstract] [Full Text] [Related]

  • 17. Design and pharmacology of selective P2-purinoceptor antagonists.
    Lambrecht G.
    J Auton Pharmacol; 1996 Dec 19; 16(6):341-4. PubMed ID: 9131412
    [Abstract] [Full Text] [Related]

  • 18. P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens.
    Bültmann R, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan 19; 349(1):74-80. PubMed ID: 8139703
    [Abstract] [Full Text] [Related]

  • 19. Discrimination between UTP- and P2-purinoceptor-mediated depolarization of rat superior cervical ganglia by 4,4'-diisothiocyanatostilbene-2,2'- disulphonate (DIDS) and uniblue A.
    Connolly GP, Harrison PJ.
    Br J Pharmacol; 1995 Jun 19; 115(3):427-32. PubMed ID: 7582453
    [Abstract] [Full Text] [Related]

  • 20. Effects of cyclopiazonic acid on contractility and ecto-ATPase activity in guinea-pig urinary bladder and vas deferens.
    Ziganshin AU, Hoyle CH, Ziganshina LE, Burnstock G.
    Br J Pharmacol; 1994 Nov 19; 113(3):669-74. PubMed ID: 7858854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.